Publications by authors named "Jairus Oketch"
ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: a multicentre, non-inferiority, adaptive, randomised controlled trial.
Lancet Glob Health
October 2022
Background: Use of medical devices represents a unique opportunity to facilitate scale-up of early infant male circumcision (EIMC) across sub-Saharan Africa. The ShangRing, a circumcision device prequalified by WHO, is approved for use in adults and adolescents and requires topical anaesthesia only. We aimed to investigate the safety and efficacy of the ShangRing versus the Mogen clamp for EIMC in infants across eastern sub-Saharan Africa.
View Article and Find Full Text PDFArticle Synopsis
- The ShangRing is a disposable circumcision device that offers a quicker, less painful alternative to traditional circumcision methods for males aged 10 and older, providing high client satisfaction and comparable adverse events.
- A study assessed the safety and effectiveness of using topical anesthesia versus injectable anesthesia during ShangRing circumcision, focusing on pain levels, ease of use, and participant satisfaction.
- Results showed that the topical anesthesia group experienced significantly less pain and fewer adverse events, leading to high satisfaction rates, with nearly all participants willing to recommend the ShangRing to others.
To assess safety of the no-flip ShangRing male circumcision technique and to determine clinical course and safety of spontaneous detachment (i.e., allowing the device to fall off), we conducted a case series of no-flip ShangRing circumcision combined with a randomized controlled trial of removal 7 days postcircumcision versus spontaneous detachment at two health facilities in Kenya.
View Article and Find Full Text PDF